| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Jun-08 | | Total Revenue | 18,965 | 242,661 | 1,043,981 | 238,660 | | Cost of Revenue | 36,154 | 38,604 | 141,934 |
-
| | | Gross Profit | (17,189) | 204,057 | 902,047 | 238,660 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,620 | 30,868 | (59,474) | 57,563 | | Non Recurring | 31,841 | (26,711) | (48,258) | 2,475 | | Others | (22,020) | 52,104 | 47,883 | 914,817 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (52,630) | 147,796 | 961,896 | (736,195) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (87,274) | (11,964) | (48,859) | 27,291 | | Earnings Before Interest And Taxes | (120,075) | 135,832 | 913,037 | (708,904) | | Interest Expense | (37,671) | 14,409 | 23,318 | 16,241 | | Income Before Tax | (82,404) | 121,423 | 889,719 | (725,145) | | Income Tax Expense | 58 | 136 | 1,665 | (164) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (82,462) | 121,287 | 888,054 | (724,981) | | | Non-recurring Events | | Discontinued Operations | (1,247) | (1,886) | 452 | 12,839 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (83,709) | 119,401 | 888,506 | (712,142) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($83,709) | $119,401 | $888,506 | ($712,142) |
|
0.74% Nasdaq 
Income Statement
